Remove 2023 Remove Access Remove DEA Remove Policy
article thumbnail

How to access and assess ketamine therapy options

The Cannigma

While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. In some instances, a medical provider or psychotherapist (or both) is present in the treatment room.

Therapy 78
article thumbnail

SXSW Opens Voting On Nearly 100 Cannabis And Psychedelics Panels For 2023 Festival

Cannabis Law Report

Marijuana Moment report on some of the panels being proposed for 2023…… Voting is now open for the public to decide which panels will make the stage at next year’s South By Southwest (SXSW) festival—and there are about 100 marijuana- and psychedelics-related proposals to pick from. Which Political Party Will Legalize Weed?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Emerge Law Group (OR): PSILOCYBIN THERAPY FOR PATIENTS WITH ADVANCED ILLNESS IN OREGON

Cannabis Law Report

Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Access Pursuant to the Oregon Psilocybin Services Act. The shelter provided by this approach depends on the policy of the U.S.

Therapy 52
article thumbnail

FDA and FTC Target Delta-8 Products

Canna Law Blog

On July 5, 2023, the FDA and FTC jointly announced six cease and desist letters to alleged delta-8 product makers. You can access the letters here. But, there’s a huge controversy about whether it can be controlled, with agencies like the DEA saying it is. FTC Policy Statement on Deception, 103 F.T.C. 174, 176 n.9

article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. 9] Experts predict that this therapy could receive full FDA approval as soon as 2023. [10] DEA and the Controlled Substances Act. Under the Controlled Substances Act of 1970, DEA classifies drugs into one of five schedules.

article thumbnail

Psychedelic Users Tend to Be ‘One With Nature’ and Are More Passionate About Climate Change, Study Finds

Veriheal

Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct. Study findings indicated that those who had previously taken LSD and psilocybin reported a greater sense of “nature relatedness.”

article thumbnail

Canopy Growth Reports First Quarter Fiscal 2022 Financial Results – The John Bonham Of Cannabis?

Cannabis Law Report

“We’re continuing to drive cost savings and operational efficiencies across the company, and remain broadly on track to our target of $150 – $200 million in fiscal 2022- fiscal 2023,” added Mike Lee , CFO. “We A replay will be accessible by webcast until 11:59 PM ET on November 4, 2021 at: [link]. Webcast Information.

Vaping 105